Blog - Page 2 of 99 - VisionGate

September 9, 2023

VisionGate Presents at the World Conference on Lung Cancer for 2023 in Singapore: PneuVision® Sputum Test for Lung Cancer Achieves High Sensitivity in Detecting Both Squamous Cell Carcinoma and Adenocarcinoma
More Information
Research
September 9, 2023

VisionGate Presents at the World Conference on Lung Cancer for 2023 in Singapore: PneuVision® Sputum Test for Lung Cancer Detects True Abnormal Cells in Non-cancer Patients with Near 100% Specificity
More Information
Research
January 16, 2023

IRB approves a new clinical study between Northwestern University Feinberg School of Medicine and VisionGate
More Information
News
January 10, 2023

#11,551,043:
MORPHOMETRIC DETECTION OF MALIGNANCY ASSOCIATED CHANGE
More Information
Patents
January 3, 2023

#11,545,237:
MORPHOMETRIC GENOTYPING OF CELLS IN LIQUID BIOPSY USING OPTICAL TOMOGRAPHY
More Information
Patents
August 30, 2022

#11,428,692:
SPECIMEN ENRICHMENT FOR OPTICAL TOMOGRAPHY CELL ANALYSIS
More Information
Patents
August 6, 2022

VisionGate Presents at the World Conference on Lung Cancer for 2022 in Vienna: New Assay for Smoking Status Based on 3D Imaging of Pulmonary Macrophages
More Information
Research
September 22, 2021

VisionGate’s New Website Illustrates its Mission to Save Lives through Early Detection of Lung Cancer
More Information
News
September 8, 2021

VisionGate Presents at the World Conference on Lung Cancer for 2021: Non-Intrusive LuCED® Test for Detection of Early-Stage Lung Cancer: Subgroup Analysis for Patients with Chronic Obstructive Pulmonary Disease (COPD)
More Information
Research
July 20, 2021

#11,069,054:
SYSTEM AND METHOD FOR AUTOMATED DETECTION AND MONITORING OF DYSPLASIA AND ADMINISTRATION OF CHEMOPREVENTION
More Information
Patents

Previous 123 Next